Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Leesburg › NPI 1679591440
Physician

Loudoun Medical Group, PC

Loudoun Medical Group, PC was paid $12.37M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 26% of everything it billed.

33Billing provider infoLOUDOUN MEDICAL GROUP, PC
LEESBURG, VA 20176
33aNPI1679591440assigned 07/18/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$12.37M
24GClaims376,867
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Obstetrics & Gynecology Physician providers in Virginia

Rank by total paid#1 of 243
Median peer was paid$8K
This provider vs. median1,521×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201829,658$722K
201942,488$1.18M
202041,188$1.44M
202160,369$2.01M
202276,640$2.64M
202373,951$2.55M
2024incomplete52,573$1.82M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 54,839 45,576 $3.27M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 17% 45,978 38,994 $2.07M
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 11% 19,187 16,258 $1.40M
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 6.7% 7,401 6,716 $831K
99232 Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity 3.7% 20,850 4,592 $461K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 3.1% 6,276 5,357 $384K
95810 Polysomnography; sleep staging with 4 or more additional parameters 2.6% 749 697 $316K
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m 2.5% 8,669 2,624 $303K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 2.4% 3,144 2,979 $300K
92015 Determination of refractive state 2.0% 16,746 15,402 $252K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.8% 3,601 3,356 $221K
99223 Prolong inpt eval add15 m 1.8% 3,136 2,751 $219K
171 more codes
95811 1.7% 568 $214K
92250 1.7% 13,964 $205K
99215 Doctor's office visit, returning patient (complex) 1.5% 2,191 $190K
90837 Psychotherapy session, about an hour 1.4% 1,478 $171K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 4,180 $99K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 927 $90K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 2,016 $82K
99222 Initial hospital care, per day, moderate complexity <1% 1,832 $64K
92060 <1% 1,271 $63K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 4,772 $58K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,076 $56K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 209 $49K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,930 $46K
92083 <1% 2,027 $41K
80061 Lipid panel <1% 5,356 $36K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 827 $35K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,134 $33K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,743 $32K
80050 General health panel <1% 2,911 $31K
90686 <1% 2,799 $31K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 411 $29K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,986 $29K
92134 <1% 1,630 $26K
99244 Office or other outpatient consultation, moderate to high complexity <1% 216 $26K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 3,025 $25K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 233 $23K
3008F <1% 13,969 $23K
1159F <1% 15,996 $22K
73630 <1% 1,047 $22K
92002 <1% 298 $22K
83036 Hemoglobin; glycosylated (A1C) <1% 4,901 $21K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 266 $21K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 4,570 $20K
80053 Comprehensive metabolic panel <1% 4,672 $18K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 229 $17K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 235 $17K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 490 $15K
83861 <1% 4,430 $15K
36415 Collection of venous blood by venipuncture <1% 11,359 $14K
87428 <1% 294 $13K
88312 <1% 155 $12K
92133 <1% 974 $11K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 5,595 $11K
99000 <1% 6,800 $11K
94010 <1% 730 $10K
99308 Subsequent nursing facility care, per day, straightforward <1% 1,740 $10K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 151 $10K
88342 <1% 180 $9K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 124 $9K
82607 <1% 1,197 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 223 $9K
81002 <1% 3,672 $8K
2010F <1% 4,653 $8K
84443 Thyroid stimulating hormone (TSH) <1% 1,699 $8K
88313 <1% 124 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 219 $7K
0502F <1% 1,338 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 924 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 118 $6K
84153 <1% 681 $6K
84439 <1% 1,497 $6K
92557 <1% 209 $6K
87631 <1% 83 $6K
95800 <1% 45 $5K
90670 <1% 132 $4K
2001F <1% 2,703 $4K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 56 $4K
92225 <1% 1,264 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,272 $4K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits <1% 67 $3K
1160F <1% 3,645 $3K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 51 $3K
82728 <1% 596 $3K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 147 $3K
67028 Intravitreal injection of a pharmacologic agent <1% 67 $3K
81001 <1% 1,142 $2K
99490 Ccm add 20min <1% 1,078 $2K
99307 <1% 908 $2K
2000F <1% 884 $2K
82747 <1% 316 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 24 $2K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 33 $2K
90461 <1% 1,157 $2K
94729 <1% 54 $2K
95115 <1% 214 $2K
92136 <1% 59 $1K
83550 <1% 379 $1K
87081 <1% 239 $1K
J1756 Injection, iron sucrose, 1 mg <1% 41 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 16 $1K
94727 <1% 54 $1K
93015 <1% 25 $1K
83540 <1% 396 $1K
91320 <1% 15 $1K
94760 <1% 2,176 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 944 $1K
84481 <1% 149 $1K
93000 <1% 171 $974.89
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $956.06
83516 <1% 743 $935.41
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 132 $873.69
90648 <1% 87 $862.07
92587 <1% 181 $837.33
88738 <1% 342 $822.35
87634 <1% 15 $764.17
99173 <1% 313 $702.95
87807 <1% 59 $702.81
82652 <1% 67 $690.89
81015 <1% 388 $688.72
90961 <1% 14 $664.82
99402 <1% 29 $654.45
90680 <1% 30 $648.56
97161 <1% 15 $620.66
96127 <1% 137 $593.37
0071A <1% 13 $524.00
0503F <1% 48 $512.50
0013A <1% 14 $492.00
73560 <1% 28 $460.56
84702 <1% 159 $452.51
92567 <1% 38 $447.89
0134A <1% 12 $410.00
4037F <1% 352 $400.00
90698 <1% 15 $394.80
92226 <1% 38 $382.29
73562 <1% 18 $370.73
99306 Prolong nursin fac eval 15m <1% 22 $351.16
99439 <1% 139 $350.48
90653 <1% 12 $326.69
51798 <1% 54 $324.45
92202 <1% 55 $285.62
99487 Ccm add 20min <1% 35 $276.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 14 $269.98
3078F <1% 38 $250.00
90723 <1% 19 $225.92
92201 <1% 16 $213.20
90674 <1% 14 $177.24
82570 <1% 55 $168.76
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 32 $154.32
90480 <1% 13 $142.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 12 $139.44
90756 <1% 49 $137.52
90651 <1% 12 $132.00
4274F <1% 35 $125.00
82043 <1% 55 $120.07
92551 <1% 12 $118.80
90472 Immunization administration, each additional vaccine (list separately) <1% 91 $105.16
99001 <1% 269 $94.95
80048 Basic metabolic panel (calcium, ionized) <1% 15 $85.45
81025 <1% 12 $80.67
G0008 Administration of influenza virus vaccine <1% 75 $45.38
90694 <1% 15 $40.16
90688 <1% 13 $29.50
85018 <1% 16 $26.31
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 71 $6.30
36416 <1% 134 $6.21
91300 <1% 63 $0.30
91301 <1% 18 $0.13
91313 <1% 12 $0.06
91307 <1% 13 $0.04
3074F 0% 18 $0.00
3080F 0% 15 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 35 $0.00
3061F 0% 32 $0.00
4010F 0% 19 $0.00
83721 0% 84 $0.00
99072 0% 109 $0.00
2022F 0% 31 $0.00
3077F 0% 29 $0.00
G0444 Annual depression screening, 5 to 15 minutes 0% 13 $0.00
3725F 0% 12 $0.00
99497 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTAMASY, MARY BETH (CEO)